Skip to search formSkip to main contentSkip to account menu

Darunavir+Ritonavir

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
543. An Integrated Safety Analysis Comparing Once-Daily Doravirine (DOR) to Darunavir+Ritonavir (DRV+r) and Efavirenz (EFV) in HIV-1-Infected, Antiretroviral Therapy (ART)-Naïve Adults
Abstract Background DOR is a novel NNRTI that has shown noninferior efficacy to DRV+r- and EFV-based regimens in phase 3 trials… 
2014
2014
Infectious colon polyp in patient with human immunodeficiency virus
immunodeficiency virus A 46-year-old Caucasianmanwas referred to our hospital because of weight loss and fatigue. He had been… 
2012
2012
Cost of switching darunavir+ritonavir (DRV+RTV) to lopinavir/ritonavir (LPV/r) in HIV‐1‐infected treatment‐naïve women of child‐bearing age (WOCBA)
Guidelines consider LPV/r a preferred protease inhibitor for use during pregnancy. When an HIV‐infected woman receiving DRV+RTV… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)